Ropivacaine 0.2% Injectable Solution — Competitive Intelligence Brief

Ropivacaine 0.2% Injectable Solution (Ropivacaine 0.2% Injectable Solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide class). Area: Anesthesia.

marketed Local anesthetic (amide class) Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Ropivacaine 0.2% Injectable Solution (Ropivacaine 0.2% Injectable Solution) — University of Minnesota. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ropivacaine 0.2% Injectable Solution TARGET	Ropivacaine 0.2% Injectable Solution	University of Minnesota	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Lidocaine-chlorprocaine combination	Lidocaine-chlorprocaine combination	Hadassah Medical Organization	marketed	Local anesthetic combination	Voltage-gated sodium channels
Lidocaine HCl 1%	Lidocaine HCl 1%	HaEmek Medical Center, Israel	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine injection flushed	Lidocaine injection flushed	Wake Forest University Health Sciences	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine infiltration	Lidocaine infiltration	Vrije Universiteit Brussel	marketed	Local anesthetic	Voltage-gated sodium channels
lidocaine pretreatment	lidocaine pretreatment	Benaroya Research Institute	marketed	Local anesthetic	Voltage-gated sodium channels
Bupivacain/levobupivacaine	Bupivacain/levobupivacaine	University Hospital, Basel, Switzerland	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide class) class)

1. Ain Shams University · 2 drugs in this class
2. Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
3. TriHealth Inc. · 2 drugs in this class
4. Centre of Postgraduate Medical Education · 2 drugs in this class
5. Bozyaka Training and Research Hospital · 2 drugs in this class
6. Complejo Hospitalario Universitario de Granada · 1 drug in this class
7. Clinique Saint-Jean, Bruxelles · 1 drug in this class
8. Hospital Clínico Universitario de Valencia · 1 drug in this class
9. Fundacion Clinica Valle del Lili · 1 drug in this class
10. Federal University of Minas Gerais · 1 drug in this class